Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Fenfluramine augmentation of serotonin reuptake blockade antiobsessional treatment.

Hollander E, DeCaria CM, Schneier FR, Schneier HA, Liebowitz MR, Klein DF.

J Clin Psychiatry. 1990 Mar;51(3):119-23.

PMID:
2106515
2.

New pharmacologic approaches to obsessive compulsive disorder.

Insel TR.

J Clin Psychiatry. 1990 Oct;51 Suppl:47-51; discussion 56-8. Review.

PMID:
2120204
3.

Fluvoxamine as an antiobsessional agent.

Goodman WK, Price LH, Rasmussen SA, Heninger GR, Charney DS.

Psychopharmacol Bull. 1989;25(1):31-5. Review.

PMID:
2505302
4.

[Value of fluoxetine in obsessive-compulsive disorder in the adult: review of the literature].

Etain B, Bonnet-Perrin E.

Encephale. 2001 May-Jun;27(3):280-9. Review. French.

PMID:
11488259
5.

Serotonin reuptake inhibitors are the treatment of choice in obsessive compulsive disorder.

Fineberg NA, Bullock T, Montgomery DB, Montgomery SA.

Int Clin Psychopharmacol. 1992 Jun;7 Suppl 1:43-7. Review. No abstract available.

PMID:
1517558
6.

[Interest of the use of pindolol in the treatment of depression: review].

Brousse G, Schmitt A, Chereau I, Eschalier A, Dubray C, Llorca PM.

Encephale. 2003 Jul-Aug;29(4 Pt 1):338-50. Review. French.

PMID:
14615704
7.

Pharmacologic treatment of obsessive-compulsive disorder: comparative studies.

Flament MF, Bisserbe JC.

J Clin Psychiatry. 1997;58 Suppl 12:18-22. Review.

8.

Fluvoxamine in the treatment of obsessive-compulsive disorder and related conditions.

Goodman WK, Ward H, Kablinger A, Murphy T.

J Clin Psychiatry. 1997;58 Suppl 5:32-49. Review.

9.

Pharmacotherapy of primary obsessive-compulsive disorder: review of the literature.

Ellingrod VL.

Pharmacotherapy. 1998 Sep-Oct;18(5):936-60. Review.

PMID:
9758307
10.

Biological approaches to treatment-resistant obsessive compulsive disorder.

Goodman WK, McDougle CJ, Barr LC, Aronson SC, Price LH.

J Clin Psychiatry. 1993 Jun;54 Suppl:16-26. Review.

PMID:
8331098
11.

Management of treatment-refractory obsessive compulsive disorder patients.

Dominguez RA, Mestre SM.

J Clin Psychiatry. 1994 Oct;55 Suppl:86-92. Review.

PMID:
7961537
12.

Serotonin and treatment in obsessive-compulsive disorder.

March JS, Gutzman LD, Jefferson JW, Greist JH.

Psychiatr Dev. 1989 Spring;7(1):1-18. Review.

PMID:
2508084
13.

Recent studies on selective serotonergic antidepressants: trazodone, fluoxetine, and fluvoxamine.

Schatzberg AF, Dessain E, O'Neil P, Katz DL, Cole JO.

J Clin Psychopharmacol. 1987 Dec;7(6 Suppl):44S-49S. Review.

PMID:
3123528
14.

[Pharmacologic treatment of obsessive compulsive disorder in the child and adolescent].

Flament MF.

Encephale. 1993 Mar-Apr;19(2):75-81. Review. French.

PMID:
8275900
15.

Pharmacologic therapy of obsessive compulsive disorder.

DeVeaugh-Geiss J.

Adv Pharmacol. 1994;30:35-52. Review.

PMID:
7833296
16.

Pharmacotherapy of obsessive-compulsive disorder.

Jermain DM, Crismon ML.

Pharmacotherapy. 1990;10(3):175-98. Review.

PMID:
2196535
17.

Fluvoxamine: a selective serotonin re-uptake inhibitor for the treatment of obsessive-compulsive disorder.

Dell'Osso B, Allen A, Hollander E.

Expert Opin Pharmacother. 2005 Dec;6(15):2727-40. Review.

PMID:
16316311
18.

Issues in the monopharmacotherapy and polypharmacotherapy of obsessive-compulsive disorder.

Laird LK.

Psychopharmacol Bull. 1996;32(4):569-78. Review.

PMID:
8993077
19.

A risk-benefit assessment of drugs used in the management of obsessive-compulsive disorder.

Carpenter LL, McDougle CJ, Epperson CN, Price LH.

Drug Saf. 1996 Aug;15(2):116-34. Review.

PMID:
8884163
20.

Beyond depression: citalopram for obsessive-compulsive disorder.

Pato MT.

Int Clin Psychopharmacol. 1999 May;14 Suppl 2:S19-26. Review.

PMID:
10471169

Supplemental Content

Support Center